Actively Recruiting

Age: 18Years - 100Years
All Genders
Healthy Volunteers
NCT04396002

Glaucoma, Visual Field Loss, and Their Association With Life Space in Older Adults

Led by University of Alabama at Birmingham · Updated on 2025-09-12

100

Participants Needed

1

Research Sites

365 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Mobility refers to a person's purposeful movement through the environment from one place to another and can be conceptualized as a continuum from bed bound (immobility) on one extreme to making excursions to distant locations on the other extreme. Primary open-angle glaucoma (POAG) is a chronic, progressive optic neuropathy that can lead to gradual loss of vision in the peripheral field and central vision. Older adults with POAG have an increased risk for motor vehicle collisions and falls. Moreover, existing studies suggest that patients with POAG exhibit more postural sway while standing as measured by a balance platform and also tend to walk more slowly than those who are normally sighted and free of ocular disease. While these disturbances likely influence mobility, there has been little research directly assessing the impact of POAG on mobility. This study will assess the impact of POAG on life space (one aspect of mobility) and will determine whether difficulties with life space are associated with difficulties experienced under conditions of dim lighting.

CONDITIONS

Official Title

Glaucoma, Visual Field Loss, and Their Association With Life Space in Older Adults

Who Can Participate

Age: 18Years - 100Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants enrolled in the Early Detection of Glaucoma Progression using a Novel Individualized Approach study or the African Descent and Glaucoma Evaluation (ADAGES) IV study
  • Controls must have no diagnosis of eye disease
Not Eligible

You will not qualify if you...

  • Patients not enrolled in either the African Descent and Glaucoma Evaluation (ADAGES) IV study or the Early Detection of Glaucoma Progression study
  • Controls with cognitive impairment that prevents completing tests

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Alabama Birmingham

Birmingham, Alabama, United States, 35294-0001

Actively Recruiting

Loading map...

Research Team

L

Lyne Racette, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here